Qube Research & Technologies (QRT)
HCA icon

Qube Research & Technologies (QRT)’s HCA Healthcare HCA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7M Sell
89,020
-94,850
-52% -$40.1M 0.03% 643
2026
Q1 		$87M Sell
183,870
-18,655
-9% -$9.39M 0.1% 249
2025
Q4 		$94.6M Buy
202,525
+183,493
+964% +$85.2M 0.1% 264
2025
Q3 		$8.11M Buy
+19,032
New +$7.38M 0.01% 1450
2025
Q2 		– Sell
-54,458
Closed -$19.6M – 3710
2025
Q1 		$18.8M Sell
54,458
-979,584
-95% -$315M 0.02% 776
2024
Q4 		$310M Buy
1,034,042
+950,697
+1,141% +$332M 0.41% 31
2024
Q3 		$33.9M Buy
+83,345
New +$30.5M 0.05% 465
2024
Q2 		– Sell
-100,511
Closed -$33.5M – 4182
2024
Q1 		$33.5M Sell
100,511
-100,604
-50% -$30.7M 0.05% 415
2023
Q4 		$54.4M Sell
201,115
-308,948
-61% -$76.4M 0.11% 244
2023
Q3 		$125M Buy
510,063
+359,861
+240% +$98.5M 0.33% 64
2023
Q2 		$45.6M Buy
+150,202
New +$41.8M 0.17% 169
2023
Q1 		– Sell
-5,131
Closed -$1.23M – 2729
2022
Q4 		$1.23M Sell
5,131
-27,631
-84% -$6.19M 0.01% 1127
2022
Q3 		$6.02M Sell
32,762
-221,892
-87% -$44.2M 0.04% 566
2022
Q2 		$42.8M Buy
254,654
+87,411
+52% +$18.8M 0.32% 62
2022
Q1 		$41.9M Buy
167,243
+164,776
+6,679% +$41.4M 0.36% 45
2021
Q4 		$634K Sell
2,467
-24,003
-91% -$5.87M ﹤0.01% 1452
2021
Q3 		$6.42M Buy
+26,470
New +$6.47M 0.08% 327
2021
Q2 		– Sell
-8,757
Closed -$1.65M – 2475
2021
Q1 		$1.65M Sell
8,757
-57,549
-87% -$10.1M 0.03% 680
2020
Q4 		$10.9M Buy
+66,306
New +$9.69M 0.16% 138
2020
Q3 		– Sell
-37,144
Closed -$3.6M – 1848
2020
Q2 		$3.6M Buy
37,144
+3,178
+9% +$330K 0.05% 462
2020
Q1 		$3.05M Buy
+33,966
New +$4.4M 0.13% 151
2019
Q2 		– Sell
-10,860
Closed -$1.42M – 475
2019
Q1 		$1.42M Buy
10,860
+8,830
+435% +$1.19M 0.19% 146
2018
Q4 		$253K Sell
2,030
-1,690
-45% -$227K 0.11% 225
2018
Q3 		$518K Buy
3,720
+3,518
+1,742% +$438K 0.07% 216
2018
Q2 		$21K Buy
+202
New +$20.4K 0.01% 707

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HCA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its HCA Healthcare (HCA) stake by 52% in Q2 2026, selling an estimated $40.1M and leaving 89,020 shares worth $34.7M. The position accounts for 0.03% of the portfolio, ranked #643.

Qube Research & Technologies (QRT) first reported a position in HCA in Q2 2018 and has held it in 25 quarters since. The position peaked at $310M in Q4 2024. 1,338 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 89,020 shares of HCA Healthcare worth $34.7M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 94,850 HCA Healthcare shares in Q2 2026, an estimated $40.1M.
  • HCA Healthcare made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #643 holding.
  • Qube Research & Technologies (QRT) first reported a position in HCA Healthcare in Q2 2018 and has held it in 25 quarters since.
  • Qube Research & Technologies (QRT)'s HCA Healthcare position peaked at $310M in Q4 2024.
  • 1,338 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.